Topical nonsteroidal anti-inflammatory drugs
Remisid is a nonsteroidal anti-inflammatory drug (NSAID) and a selective cyclooxygenase-2 inhibitor. In its anti-inflammatory activity, nimesulide at the initial inflammation stage is equivalent to indomethacin and piroxicam at an equimolar concentration.More at https://remisid.tabletki.ua/
Topical treatment of pathological conditions of the musculoskeletal system that are characterised by pain, inflammation, and stiffness, such as osteoarthritis, periarthritis, post-traumatic tendinitis, tenosynovitis, muscle sprain, heavy load on the joints.
For external use in adults. The skin surface should be washed and dried before the application of the gel. A length of approximately 3 cm of gel should be applied to the painful areas as a thin layer and lightly rubbed. The frequency of the use is 3–4 times daily.
The treatment duration is determined individually, depending on the therapy effectiveness, and is not more than 4 weeks.